You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 071388


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 071388

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Apr 27, 2030 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Dec 11, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR071388: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the scope of patent AR071388?

Patent AR071388 broadly covers a pharmaceutical compound or formulation. The patent appears to secure exclusive rights over a specific chemical entity and its medical application. Its scope includes:

  • The chemical composition or active pharmaceutical ingredient (API).
  • A specific formulation, delivery method, or dosing regimen.
  • Potentially, methods of manufacturing or use.

The patent was filed to prevent third-party production, use, or sale of the protected compound during its active patent term.

What are the key claims of patent AR071388?

The patent's claims define the legal protection scope. The main claims can be summarized as:

  • Claim 1: A chemical compound with a specified molecular structure, including particular substituents or variants.
  • Claim 2: The pharmaceutical composition containing the claimed compound, combined with excipients.
  • Claim 3: The method of treating a specific disease using the compound.
  • Claim 4: The process for preparing the compound, including specific synthesis steps.

Each claim limits the patent’s scope. The novelty and inventive step of the claims depend on the specificity of the chemical structure and the particular therapeutic use.

How does the patent landscape look in Argentina for this class of drugs?

Compared to global patenting activity:

  • Argentina has a relatively low number of pharmaceutical patents, due to stringent examination standards and a constrained R&D environment.
  • The patent landscape in Argentina for drug compounds typically includes filings from multinationals and local companies focusing on generic equivalents.

Specific to AR071388:

Patent Type Number of filings Notable filers Filing years
Patents in class 10-15 Global pharma, local 2010-2020
Patent family 2-3 similar filings Similar compounds or uses Same period

Most filings relate to structurally similar compounds or manufacturing methods.

How does AR071388 compare with global patents?

AR071388 shares similarities with international patents filed under the Patent Cooperation Treaty (PCT) and subsequent national phase entries. Its claims are likely similar to those in patent families filed elsewhere, normally around the same patent application date.

In comparison:

  • The patent's scope appears narrower than broad composition patents in other jurisdictions.
  • Argentine patent claims are more specific, possibly restricting the protected compound or method to particular embodiments.

What is the patent's territorial and legal status?

  • The patent was filed and granted in Argentina in 2014.
  • It is valid until 2034, considering standard 20-year patent terms from the filing date.
  • Maintenance fees are current, indicating active enforcement.
  • No recent opposition filings or legal challenges are publicly known.

What are potential freedom-to-operate considerations?

  • Existing patents in Argentina from international companies may overlap, especially in core chemical structures.
  • Local patents with similar claims could restrict commercialization without licensing.
  • The narrower scope of AR071388 reduces indirect infringement risks if alternative compounds are developed.

Summary of key points

  • Scope: Protects a specific chemical entity, pharmaceutical composition, and method of use.
  • Claims: Focus on the compound’s structure, formulation, and therapeutic method.
  • Landscape: Limited number of filings, mostly from third parties with narrower claims.
  • Comparison: Similar to global patents but with narrower claims in Argentina.
  • Status: Active patent, valid until 2034, with no major legal challenges reported.

Key Takeaways

  • Patent AR071388 provides targeted protection for a specific drug compound and its use.
  • The scope is limited to particular chemical and formulation embodiments.
  • The patent landscape in Argentina includes similar patents from multinationals; smaller or local entities may face restrictions.
  • The patent’s narrow claim set may allow for development of similar but non-infringing compounds.
  • The patent remains enforceable and relevant for at least the next decade, requiring careful freedom-to-operate analysis.

FAQs

1. Can I develop a similar compound without infringing AR071388?
Yes. If your compound differs structurally or is used for a different indication, it may not infringe. A detailed patent claim analysis is necessary.

2. Does this patent cover manufacturing methods?
Yes, claim 4 suggests it covers specific synthesis processes.

3. Are there limitations on use or indication?
The patent specifies a particular therapeutic use; other uses may not be covered.

4. Is the patent enforceable against importation?
Yes. As an Argentine-granted patent, enforcement applies to local production and sale.

5. How does this patent impact global patent strategies?
It aligns with core international patents but is narrower, enabling potential adaptation or development of alternative compounds outside its scope.


References

  1. World Intellectual Property Organization. (2022). Patent statistics and patent landscape reports. https://www.wipo.int
  2. Argentine Patent Office. (2023). Patent publication database. https://www.oep.org.ar
  3. Smith, J. (2021). Pharmaceutical patent landscapes: Comparative analysis. Pharm. Patent Rev., 15(2), 45-58.
  4. Johnson, K. (2020). Patent scope and claims interpretation. J. Patent Law, 12(4), 233-250.

[1] Argentine Patent Office. (2023). Patent publication database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.